Cantourage Group SE

Research Cantourage Group SE (HIGH.DE) on Bullrun: market cap EUR 62.76M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 62.76M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2023EUR 23.56M-EUR 4.27Mn/a31.5%-0.34EUR 1.02MEUR 28EUR 39.95M
FY2022EUR 603.31KEUR 9.01Kn/an/an/aEUR 3.38MEUR 91EUR 44.22M
FY2021EUR 5.22M-EUR 969.39Kn/a35.1%-0.08EUR 1.96Mn/aEUR 3.64M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-04EUR 62.76Mn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About Cantourage Group SE

Cantourage Group SE operates as a medical cannabis company in Europe and internationally. The company offers cannabis flowers, extracts, dronabinol, tetrahydrocannabinol, and cannabidiol products. It exports its products. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Cantourage Group SE's market cap?

Cantourage Group SE's market capitalization is EUR 62.76M.

What does Cantourage Group SE do?

Cantourage Group SE operates as a medical cannabis company in Europe and internationally. The company offers cannabis flowers, extracts, dronabinol, tetrahydrocannabinol, and cannabidiol products. It exports its products. The company distributes its products through pharmacies, wholesalers, and partners. Cantourage Group SE was founded in 2019 and is headquartered in Berlin, Germany.